OVP Venture Partners is a venture capital firm based in Seattle, Washington, with an additional office in Portland, Oregon. Established in 1983, OVP has a long history of investing across various sectors, including technology, healthcare, digital media, and information technology. The firm is known for its Entrepreneurs Fund, which brings together prominent entrepreneurs from the Pacific Northwest to co-invest in projects alongside OVP. This collaborative approach allows OVP to leverage the expertise and networks of industry leaders, enhancing its ability to identify promising opportunities. Over the years, OVP has navigated multiple market cycles, adapting its investment strategies to target emerging sectors and support the growth of innovative companies.
Group14 Technologies, Inc. is a leading manufacturer and supplier of advanced silicon battery technology, specializing in engineered carbon materials for energy storage solutions including electric vehicles and consumer electronics. Founded in 2015 and headquartered in Woodinville, Washington, the company collaborates with clients representing 95% of global battery production. Group14 develops innovative battery materials that enhance energy performance in lithium-ion systems, providing clients with significantly increased lithium capacity while ensuring safety and longevity. The company operates a joint venture in South Korea and is expanding its manufacturing capabilities worldwide to meet the growing demand for silicon battery materials, aiming to enable a future where all rechargeable devices are powered by advanced battery technology.
Group14 Technologies
Series A in 2019
Group14 Technologies, Inc. is a leading manufacturer and supplier of advanced silicon battery technology, specializing in engineered carbon materials for energy storage solutions including electric vehicles and consumer electronics. Founded in 2015 and headquartered in Woodinville, Washington, the company collaborates with clients representing 95% of global battery production. Group14 develops innovative battery materials that enhance energy performance in lithium-ion systems, providing clients with significantly increased lithium capacity while ensuring safety and longevity. The company operates a joint venture in South Korea and is expanding its manufacturing capabilities worldwide to meet the growing demand for silicon battery materials, aiming to enable a future where all rechargeable devices are powered by advanced battery technology.
Verdezyne
Venture Round in 2014
Verdezyne is a private company focused on synthetic biology, utilizing its expertise and advanced computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. By optimizing commercial fermentation processes, Verdezyne produces renewable chemical alternatives to petrochemicals. The company’s innovative platform combines synthetic biology with established manufacturing technologies to create a wide range of building blocks, offering sustainable and cost-effective solutions for everyday chemicals and additives. This approach aims to reduce reliance on oil and transform traditional chemical production methods.
Adapx
Venture Round in 2013
Adapx, Inc. is a software company based in Seattle, Washington, that specializes in user interface solutions designed to enhance data capture and integration for businesses and agencies. The company's primary offering, Capturx, enables users to convert natural speech, sketches, and handwriting into structured data for Microsoft Office and other backend systems. This solution helps streamline workflows by eliminating the need for data transcription and allows for efficient data collection through various mediums, including paper, touchscreens, and mobile devices. Adapx provides several tailored applications, such as Capturx for SharePoint, Capturx Forms for Excel, and Capturx for ArcGIS Desktop, among others. The company serves multiple industries, including manufacturing, defense, healthcare, and utilities. Additionally, Adapx has established strategic partnerships with major organizations like Microsoft and ESRI to enhance its product offerings. Founded in 1999, Adapx was previously known as Natural Interaction Systems.
Aggregate Knowledge
Venture Round in 2013
Aggregate Knowledge is a media intelligence company that specializes in providing advertisers and agencies with a comprehensive platform to identify and reach high-performing customers. Its patented media intelligence platform integrates both media and audience data, allowing marketers to optimize their advertising strategies effectively. By delivering real-time personalization and audience-centric display optimization services, Aggregate Knowledge enables clients to execute tailored advertising campaigns that enhance media spend efficiency, increase reach, and drive higher sales. The company's focus on combining data management solutions with actionable insights positions it as a pivotal player in the advertising technology landscape.
Aggregate Knowledge
Series E in 2013
Aggregate Knowledge is a media intelligence company that specializes in providing advertisers and agencies with a comprehensive platform to identify and reach high-performing customers. Its patented media intelligence platform integrates both media and audience data, allowing marketers to optimize their advertising strategies effectively. By delivering real-time personalization and audience-centric display optimization services, Aggregate Knowledge enables clients to execute tailored advertising campaigns that enhance media spend efficiency, increase reach, and drive higher sales. The company's focus on combining data management solutions with actionable insights positions it as a pivotal player in the advertising technology landscape.
EnerG2
Venture Round in 2013
EnerG2, Inc. is a manufacturer of engineered carbon materials designed for energy storage devices, established in 2003 and headquartered in Seattle, Washington, with an additional facility in Albany, Oregon. The company specializes in producing advanced nano-structured carbon materials that improve the performance of various energy storage applications, including lead acid batteries, ultracapacitors, and lithium-ion batteries. EnerG2 employs proprietary manufacturing technologies to create high surface area materials that enhance power density and extend cycle life, thereby enabling customers to optimize the charge acceptance and longevity of their energy storage devices. Through its innovative approach, EnerG2 aims to address the limitations of traditional carbon materials and support the growing demand for efficient energy storage solutions.
NanoString Technologies
Series E in 2012
NanoString Technologies, Inc. is a provider of life science tools focused on translational research and molecular diagnostics, headquartered in Seattle, Washington. Established in 2003, the company utilizes a unique digital molecular barcoding technology to create a range of products that facilitate gene expression analysis, microRNA studies, and copy number variation detection. Key offerings include the nCounter Analysis System, which consists of the nCounter MAX and FLEX systems, and the nCounter SPRINT Profiler, all designed for automated sample processing and data collection. The nSolver Analysis Software aids researchers in data normalization and analysis. Additionally, NanoString provides various custom CodeSets and panels tailored for specific applications, including cancer profiling and autoimmune disease research. The company is advancing the field of spatial genomics with its GeoMx Digital Spatial Profiler system and is developing the Hyb & Seq molecular profiling system for gene sequence analysis. NanoString collaborates with several pharmaceutical companies and research institutions to enhance its product offerings and expand its impact in the scientific community.
Adapx
Venture Round in 2012
Adapx, Inc. is a software company based in Seattle, Washington, that specializes in user interface solutions designed to enhance data capture and integration for businesses and agencies. The company's primary offering, Capturx, enables users to convert natural speech, sketches, and handwriting into structured data for Microsoft Office and other backend systems. This solution helps streamline workflows by eliminating the need for data transcription and allows for efficient data collection through various mediums, including paper, touchscreens, and mobile devices. Adapx provides several tailored applications, such as Capturx for SharePoint, Capturx Forms for Excel, and Capturx for ArcGIS Desktop, among others. The company serves multiple industries, including manufacturing, defense, healthcare, and utilities. Additionally, Adapx has established strategic partnerships with major organizations like Microsoft and ESRI to enhance its product offerings. Founded in 1999, Adapx was previously known as Natural Interaction Systems.
Symform
Series B in 2012
Symform is a provider of cost-effective storage and backup services aimed at addressing large-scale distributed data management challenges. The company offers a unique solution known as the Symform Cooperative Storage Cloud, which integrates disaster recovery, data security, and distributed networking by leveraging the power of the Internet. Its model allows members to contribute unused server space, which corresponds to the amount of online storage they utilize. This peer-to-peer framework not only enhances data accessibility but also eliminates the reliance on traditional backup tapes and data center-based services. Symform manages the ongoing security and administration of the storage cloud, enabling users to enjoy unlimited storage space while ensuring robust data protection and recovery capabilities.
DataSphere Technologies
Series D in 2012
DataSphere specializes in web technology and advertising solutions aimed at enhancing neighborhood-level user engagement and monetization for media companies. By offering an advertising platform, DataSphere connects business owners with customers, making mobile marketing accessible and affordable. The platform caters to a diverse clientele, ranging from small local businesses to large brands with multiple locations. Its primary goal is to help businesses differentiate their brands and generate interest from local consumers, thereby facilitating their success in a competitive market.
GenoLogics
Series D in 2012
GenoLogics, Inc. is a company that specializes in laboratory information management systems designed to enhance the diagnosis and treatment of diseases. Based in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers the BaseSpace Clarity LIMS, a solution utilized by research and clinical laboratories to efficiently track samples from receipt to result. This system aims to reduce costs, improve accuracy, and ensure rigorous quality control. The company focuses on translational medicine, genomics sequencing, systems biology research, and data management across multiple laboratories, facilitating collaborative initiatives in biomedical research. Founded in 2002, GenoLogics operates as a subsidiary of Illumina Inc., contributing to advancements in early disease detection, prevention, and treatment.
Symform
Venture Round in 2012
Symform is a provider of cost-effective storage and backup services aimed at addressing large-scale distributed data management challenges. The company offers a unique solution known as the Symform Cooperative Storage Cloud, which integrates disaster recovery, data security, and distributed networking by leveraging the power of the Internet. Its model allows members to contribute unused server space, which corresponds to the amount of online storage they utilize. This peer-to-peer framework not only enhances data accessibility but also eliminates the reliance on traditional backup tapes and data center-based services. Symform manages the ongoing security and administration of the storage cloud, enabling users to enjoy unlimited storage space while ensuring robust data protection and recovery capabilities.
Groove Biopharma
Series B in 2011
Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) are involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma’s core technology addresses a new avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA. Using exclusive technology, Groove Biopharma is generating a series of lead candidates with the potential to be best-in-class therapeutics. By incorporating proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presents promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.
RedSeal
Venture Round in 2011
RedSeal, Inc. specializes in cybersecurity analytics solutions aimed at enhancing the digital resilience of organizations and government agencies globally. Founded in 2004 and based in San Jose, California, RedSeal's platform creates detailed network models and assesses security risks, allowing users to prioritize actions for remediation. By identifying potential attack paths to critical assets, the solution helps organizations allocate their limited security resources effectively, improve incident response times, and maintain comprehensive network visibility. RedSeal's offerings support compliance with various industry regulations and standards, while its technology integrates seamlessly with leading security tools and infrastructure providers. The company serves a diverse client base, including major financial institutions, retail companies, and U.S. federal agencies. RedSeal has established partnerships with top network infrastructure suppliers and is backed by several notable venture capital firms.
NanoString Technologies
Series D in 2011
NanoString Technologies, Inc. is a provider of life science tools focused on translational research and molecular diagnostics, headquartered in Seattle, Washington. Established in 2003, the company utilizes a unique digital molecular barcoding technology to create a range of products that facilitate gene expression analysis, microRNA studies, and copy number variation detection. Key offerings include the nCounter Analysis System, which consists of the nCounter MAX and FLEX systems, and the nCounter SPRINT Profiler, all designed for automated sample processing and data collection. The nSolver Analysis Software aids researchers in data normalization and analysis. Additionally, NanoString provides various custom CodeSets and panels tailored for specific applications, including cancer profiling and autoimmune disease research. The company is advancing the field of spatial genomics with its GeoMx Digital Spatial Profiler system and is developing the Hyb & Seq molecular profiling system for gene sequence analysis. NanoString collaborates with several pharmaceutical companies and research institutions to enhance its product offerings and expand its impact in the scientific community.
Oncofactor
Series A in 2011
Oncofactor is a Seattle, Washington-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system.
PrecisionDemand
Series C in 2011
PrecisionDemand is a television media agency located in Seattle and New York, focused on enhancing the effectiveness of advertising through advanced analytics. The company specializes in targeting TV audiences with high precision, utilizing a technology platform that incorporates extensive demographic and behavioral data. PrecisionDemand's Buyometric targeting system allows clients to significantly reduce their cost-per-sale while accurately predicting sales volumes across various channels. In addition to its targeting capabilities, the company provides a suite of direct marketing services that includes tracking and analyzing marketing campaigns, customer interactions, and operational metrics. Their offerings include detailed dashboards and reports that measure campaign performance, conversion rates, and revenue, enabling clients to make informed decisions to optimize their media purchases. With a team of experts in media, technology, and data mining, PrecisionDemand aims to deliver value and improve marketing outcomes for its clients.
Adapx
Venture Round in 2011
Adapx, Inc. is a software company based in Seattle, Washington, that specializes in user interface solutions designed to enhance data capture and integration for businesses and agencies. The company's primary offering, Capturx, enables users to convert natural speech, sketches, and handwriting into structured data for Microsoft Office and other backend systems. This solution helps streamline workflows by eliminating the need for data transcription and allows for efficient data collection through various mediums, including paper, touchscreens, and mobile devices. Adapx provides several tailored applications, such as Capturx for SharePoint, Capturx Forms for Excel, and Capturx for ArcGIS Desktop, among others. The company serves multiple industries, including manufacturing, defense, healthcare, and utilities. Additionally, Adapx has established strategic partnerships with major organizations like Microsoft and ESRI to enhance its product offerings. Founded in 1999, Adapx was previously known as Natural Interaction Systems.
Verdezyne
Venture Round in 2011
Verdezyne is a private company focused on synthetic biology, utilizing its expertise and advanced computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. By optimizing commercial fermentation processes, Verdezyne produces renewable chemical alternatives to petrochemicals. The company’s innovative platform combines synthetic biology with established manufacturing technologies to create a wide range of building blocks, offering sustainable and cost-effective solutions for everyday chemicals and additives. This approach aims to reduce reliance on oil and transform traditional chemical production methods.
Fate Therapeutics
Series B in 2011
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing programmed cellular immunotherapies for cancer and immune disorders. The company specializes in NK- and T-cell immuno-oncology programs, with a diverse pipeline that includes candidates such as FT516 and FT596 for treating various hematologic malignancies, FT538 for acute myeloid leukemia and multiple myeloma, and FT500 for advanced solid tumors. Fate Therapeutics employs advanced techniques involving induced pluripotent stem cells (iPSCs) to create engineered product candidates, which are designed to be off-the-shelf solutions. The company has established strategic collaborations with notable partners, including Ono Pharmaceutical Co. Ltd. and Janssen Biotech, to enhance its research and development capabilities. Founded in 2007, Fate Therapeutics aims to leverage cutting-edge science to create innovative therapies that restore health by modulating the properties of stem cells.
Cradlepoint
Venture Round in 2011
CradlePoint, Inc. is a provider of secure cloud-managed networking solutions designed for the Distributed Enterprise, specializing in 3G, 4G, LTE, and 5G technologies. Founded in 2004 and headquartered in Boise, Idaho, the company offers a range of products including wireless routers, edge defense solutions, and the Cradlepoint NetCloud platform. This platform extends the capabilities of multi-function routers and IoT gateways with cloud-based management and software-defined networking services. CradlePoint’s solutions enable organizations to maintain connectivity and security across diverse environments, including branches, mobile workforces, and IoT networks. The company serves over 15,000 enterprise and government customers globally, including many of the world's top retailers and Fortune 100 companies. With additional offices in the UK, Australia, and Japan, CradlePoint's technology supports seamless and secure connections for critical sites, workforces, vehicles, and devices.
Acylin Therapeutics
Series A in 2011
Acylin Therapeutics is the first company focused on developing inhibitors of cellular acetylation, an enzymatic mechanism fundamental to the molecular pathology of cancer, metabolic disease, and neurodegeneration. Recent discoveries by Acylin founders and other investigators have revealed protein acetylation as a cellular signal transduction regulator potentially as ubiquitous and important as phosphorylation by kinase enzymes. The Company has developed a platform technology to design specific acyltransferase inhibitors based on crystal structures, novel medicinal chemical approaches, and mechanistic understanding. Acylin has prioritized the p300 and CBP histone acetyl transferases [HATs] for initial drug discovery.
Carbonflow
Series B in 2010
CarbonFlow is a developer of carbon trading software focused on addressing climate change by streamlining the creation and marketing of carbon offsets. Founded in 2006, the company aims to lower the costs and time associated with generating carbon credits. Its software suite enhances productivity while reducing administrative expenses and financial risks linked to managing greenhouse gas offset projects. Additionally, CarbonFlow facilitates the delivery of certified carbon credits to buyers and sellers globally, thereby supporting the acceleration of carbon reduction initiatives.
DataSphere Technologies
Series C in 2010
DataSphere specializes in web technology and advertising solutions aimed at enhancing neighborhood-level user engagement and monetization for media companies. By offering an advertising platform, DataSphere connects business owners with customers, making mobile marketing accessible and affordable. The platform caters to a diverse clientele, ranging from small local businesses to large brands with multiple locations. Its primary goal is to help businesses differentiate their brands and generate interest from local consumers, thereby facilitating their success in a competitive market.
Complete Genomics
Series E in 2010
Complete Genomics specializes in high-quality, affordable DNA sequencing and analysis, facilitating large-scale research into the genetic mechanisms of drug responses and complex diseases. The company has developed a comprehensive genomics analysis platform that integrates proprietary human sequencing technology with advanced informatics and data management software. This approach ensures that customers receive ready-to-use data for genome-based research, supporting advancements in personalized medicine and broader genetic studies. By combining innovative technology with a unique market strategy, Complete Genomics aims to transform the landscape of DNA sequencing.
Symform
Venture Round in 2010
Symform is a provider of cost-effective storage and backup services aimed at addressing large-scale distributed data management challenges. The company offers a unique solution known as the Symform Cooperative Storage Cloud, which integrates disaster recovery, data security, and distributed networking by leveraging the power of the Internet. Its model allows members to contribute unused server space, which corresponds to the amount of online storage they utilize. This peer-to-peer framework not only enhances data accessibility but also eliminates the reliance on traditional backup tapes and data center-based services. Symform manages the ongoing security and administration of the storage cloud, enabling users to enjoy unlimited storage space while ensuring robust data protection and recovery capabilities.
Tigo Energy
Series C in 2010
Tigo Energy, Inc. specializes in developing module-level power electronics and module optimizer technology for the solar industry. The company offers solar optimizers and comprehensive software solutions that include module-level monitoring for utility, commercial, and residential photovoltaic (PV) arrays, as well as a mobile application for solar management. Tigo Energy also provides communication solutions, such as gateways and a Maximizer Management Unit, which facilitate communication between optimizers and inverters. Its products cater to a diverse range of markets, including residential, commercial, utility, third-party finance, schools, and government sectors, and are distributed through various channels. Founded in 2007 and headquartered in Campbell, California, with an additional office in Tuscany, Italy, Tigo Energy operates globally across the United States, Europe, Japan, China, Australia, Brazil, and the Middle East. The company's focus is on enhancing safety, increasing energy yield, and reducing operating costs, ultimately improving the efficiency and reliability of solar installations.
Groove Biopharma
Series A in 2010
Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) are involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma’s core technology addresses a new avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA. Using exclusive technology, Groove Biopharma is generating a series of lead candidates with the potential to be best-in-class therapeutics. By incorporating proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presents promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.
PrecisionDemand
Series B in 2010
PrecisionDemand is a television media agency located in Seattle and New York, focused on enhancing the effectiveness of advertising through advanced analytics. The company specializes in targeting TV audiences with high precision, utilizing a technology platform that incorporates extensive demographic and behavioral data. PrecisionDemand's Buyometric targeting system allows clients to significantly reduce their cost-per-sale while accurately predicting sales volumes across various channels. In addition to its targeting capabilities, the company provides a suite of direct marketing services that includes tracking and analyzing marketing campaigns, customer interactions, and operational metrics. Their offerings include detailed dashboards and reports that measure campaign performance, conversion rates, and revenue, enabling clients to make informed decisions to optimize their media purchases. With a team of experts in media, technology, and data mining, PrecisionDemand aims to deliver value and improve marketing outcomes for its clients.
Verdezyne
Venture Round in 2010
Verdezyne is a private company focused on synthetic biology, utilizing its expertise and advanced computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. By optimizing commercial fermentation processes, Verdezyne produces renewable chemical alternatives to petrochemicals. The company’s innovative platform combines synthetic biology with established manufacturing technologies to create a wide range of building blocks, offering sustainable and cost-effective solutions for everyday chemicals and additives. This approach aims to reduce reliance on oil and transform traditional chemical production methods.
Aggregate Knowledge
Series C in 2010
Aggregate Knowledge is a media intelligence company that specializes in providing advertisers and agencies with a comprehensive platform to identify and reach high-performing customers. Its patented media intelligence platform integrates both media and audience data, allowing marketers to optimize their advertising strategies effectively. By delivering real-time personalization and audience-centric display optimization services, Aggregate Knowledge enables clients to execute tailored advertising campaigns that enhance media spend efficiency, increase reach, and drive higher sales. The company's focus on combining data management solutions with actionable insights positions it as a pivotal player in the advertising technology landscape.
Fate Therapeutics
Series B in 2009
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing programmed cellular immunotherapies for cancer and immune disorders. The company specializes in NK- and T-cell immuno-oncology programs, with a diverse pipeline that includes candidates such as FT516 and FT596 for treating various hematologic malignancies, FT538 for acute myeloid leukemia and multiple myeloma, and FT500 for advanced solid tumors. Fate Therapeutics employs advanced techniques involving induced pluripotent stem cells (iPSCs) to create engineered product candidates, which are designed to be off-the-shelf solutions. The company has established strategic collaborations with notable partners, including Ono Pharmaceutical Co. Ltd. and Janssen Biotech, to enhance its research and development capabilities. Founded in 2007, Fate Therapeutics aims to leverage cutting-edge science to create innovative therapies that restore health by modulating the properties of stem cells.
Verdezyne
Venture Round in 2009
Verdezyne is a private company focused on synthetic biology, utilizing its expertise and advanced computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. By optimizing commercial fermentation processes, Verdezyne produces renewable chemical alternatives to petrochemicals. The company’s innovative platform combines synthetic biology with established manufacturing technologies to create a wide range of building blocks, offering sustainable and cost-effective solutions for everyday chemicals and additives. This approach aims to reduce reliance on oil and transform traditional chemical production methods.
RedSeal
Series C in 2009
RedSeal, Inc. specializes in cybersecurity analytics solutions aimed at enhancing the digital resilience of organizations and government agencies globally. Founded in 2004 and based in San Jose, California, RedSeal's platform creates detailed network models and assesses security risks, allowing users to prioritize actions for remediation. By identifying potential attack paths to critical assets, the solution helps organizations allocate their limited security resources effectively, improve incident response times, and maintain comprehensive network visibility. RedSeal's offerings support compliance with various industry regulations and standards, while its technology integrates seamlessly with leading security tools and infrastructure providers. The company serves a diverse client base, including major financial institutions, retail companies, and U.S. federal agencies. RedSeal has established partnerships with top network infrastructure suppliers and is backed by several notable venture capital firms.
PrecisionDemand
Series B in 2009
PrecisionDemand is a television media agency located in Seattle and New York, focused on enhancing the effectiveness of advertising through advanced analytics. The company specializes in targeting TV audiences with high precision, utilizing a technology platform that incorporates extensive demographic and behavioral data. PrecisionDemand's Buyometric targeting system allows clients to significantly reduce their cost-per-sale while accurately predicting sales volumes across various channels. In addition to its targeting capabilities, the company provides a suite of direct marketing services that includes tracking and analyzing marketing campaigns, customer interactions, and operational metrics. Their offerings include detailed dashboards and reports that measure campaign performance, conversion rates, and revenue, enabling clients to make informed decisions to optimize their media purchases. With a team of experts in media, technology, and data mining, PrecisionDemand aims to deliver value and improve marketing outcomes for its clients.
Complete Genomics
Series D in 2009
Complete Genomics specializes in high-quality, affordable DNA sequencing and analysis, facilitating large-scale research into the genetic mechanisms of drug responses and complex diseases. The company has developed a comprehensive genomics analysis platform that integrates proprietary human sequencing technology with advanced informatics and data management software. This approach ensures that customers receive ready-to-use data for genome-based research, supporting advancements in personalized medicine and broader genetic studies. By combining innovative technology with a unique market strategy, Complete Genomics aims to transform the landscape of DNA sequencing.
Translarity
Series B in 2009
Translarity is a pioneering company in the semiconductor wafer test sector, specializing in advanced probe card solutions. Based in Silicon Valley, the company has introduced a disruptive full-wafer testing approach that emphasizes low cost, high performance, and reduced cycle times. In 2017, Translarity expanded its capabilities through the acquisition of BucklingBeam, enhancing its product offerings with a comprehensive range of probe card solutions, including full probe cards and vertical probe head technologies. The company's innovative Space Translator™ technology positions it well to meet the fast-evolving demands of probe technologies. With a strong management team and significant backing from financial investors, Translarity has built a robust innovation pipeline and intellectual property portfolio, boasting over 45 issued patents and more than 50 additional patents filed. The company aims to address critical challenges in semiconductor testing, facilitating efficient wafer-level and advanced package tests in the industry.
Novomer
Series B in 2009
Novomer is a materials company focused on developing high-performance, eco-friendly plastics, polymers, and chemicals. Established in 2004 and based in Waltham, Massachusetts, the company leverages proprietary catalytic technology to convert carbon dioxide and other renewable materials into cost-effective industrial products. This innovative approach combines traditional chemical feedstocks with carbon, enabling the sustainable synthesis of a range of chemicals and materials. Novomer’s technology not only offers competitive pricing but also contributes to environmental sustainability by addressing global warming and climate change challenges through the use of carbon in industrial applications.
Limerick BioPharma
Series C in 2009
Limerick BioPharma focuses on creating innovative pharmaceutical compounds designed to enhance the efficacy of existing and experimental drugs, while reducing harmful side effects on non-targeted organs and tissues. The company aims to improve patient quality of life by developing adjunctive therapies that work in conjunction with other medications. Additionally, Limerick BioPharma is advancing novel treatments for metabolic diseases, specifically targeting conditions like hypercholesteremia and hyperglycemia. They employ advanced methodologies to simulate blood-tissue barrier activity both in laboratory settings and in living organisms, positioning them at the forefront of research in metabolic disorders and solid organ transplantation.
Tigo Energy
Series B in 2009
Tigo Energy, Inc. specializes in developing module-level power electronics and module optimizer technology for the solar industry. The company offers solar optimizers and comprehensive software solutions that include module-level monitoring for utility, commercial, and residential photovoltaic (PV) arrays, as well as a mobile application for solar management. Tigo Energy also provides communication solutions, such as gateways and a Maximizer Management Unit, which facilitate communication between optimizers and inverters. Its products cater to a diverse range of markets, including residential, commercial, utility, third-party finance, schools, and government sectors, and are distributed through various channels. Founded in 2007 and headquartered in Campbell, California, with an additional office in Tuscany, Italy, Tigo Energy operates globally across the United States, Europe, Japan, China, Australia, Brazil, and the Middle East. The company's focus is on enhancing safety, increasing energy yield, and reducing operating costs, ultimately improving the efficiency and reliability of solar installations.
Symform
Series A in 2009
Symform is a provider of cost-effective storage and backup services aimed at addressing large-scale distributed data management challenges. The company offers a unique solution known as the Symform Cooperative Storage Cloud, which integrates disaster recovery, data security, and distributed networking by leveraging the power of the Internet. Its model allows members to contribute unused server space, which corresponds to the amount of online storage they utilize. This peer-to-peer framework not only enhances data accessibility but also eliminates the reliance on traditional backup tapes and data center-based services. Symform manages the ongoing security and administration of the storage cloud, enabling users to enjoy unlimited storage space while ensuring robust data protection and recovery capabilities.
Adapx
Series B in 2009
Adapx, Inc. is a software company based in Seattle, Washington, that specializes in user interface solutions designed to enhance data capture and integration for businesses and agencies. The company's primary offering, Capturx, enables users to convert natural speech, sketches, and handwriting into structured data for Microsoft Office and other backend systems. This solution helps streamline workflows by eliminating the need for data transcription and allows for efficient data collection through various mediums, including paper, touchscreens, and mobile devices. Adapx provides several tailored applications, such as Capturx for SharePoint, Capturx Forms for Excel, and Capturx for ArcGIS Desktop, among others. The company serves multiple industries, including manufacturing, defense, healthcare, and utilities. Additionally, Adapx has established strategic partnerships with major organizations like Microsoft and ESRI to enhance its product offerings. Founded in 1999, Adapx was previously known as Natural Interaction Systems.
GenoLogics
Series C in 2009
GenoLogics, Inc. is a company that specializes in laboratory information management systems designed to enhance the diagnosis and treatment of diseases. Based in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers the BaseSpace Clarity LIMS, a solution utilized by research and clinical laboratories to efficiently track samples from receipt to result. This system aims to reduce costs, improve accuracy, and ensure rigorous quality control. The company focuses on translational medicine, genomics sequencing, systems biology research, and data management across multiple laboratories, facilitating collaborative initiatives in biomedical research. Founded in 2002, GenoLogics operates as a subsidiary of Illumina Inc., contributing to advancements in early disease detection, prevention, and treatment.
Napera Networks
Series A in 2008
Napera Networks specializes in cloud-based active network management services aimed at assisting small and medium-sized enterprises in minimizing the cost and complexity of IT management. The company offers innovative network and security management solutions, including the Napera N24, which ensures gigabit-speed switched-network access for authorized users with healthy devices while restricting access for guests or compromised devices. Additionally, the Napera N24S complements the N24 appliance by providing 24 ports of gigabit Ethernet and an option for four fiber connections, enhancing the overall network capabilities for businesses. Acquired by OPSWAT, Napera Networks continues to focus on delivering effective tools for managing network security and performance.
EnerG2
Series A in 2008
EnerG2, Inc. is a manufacturer of engineered carbon materials designed for energy storage devices, established in 2003 and headquartered in Seattle, Washington, with an additional facility in Albany, Oregon. The company specializes in producing advanced nano-structured carbon materials that improve the performance of various energy storage applications, including lead acid batteries, ultracapacitors, and lithium-ion batteries. EnerG2 employs proprietary manufacturing technologies to create high surface area materials that enhance power density and extend cycle life, thereby enabling customers to optimize the charge acceptance and longevity of their energy storage devices. Through its innovative approach, EnerG2 aims to address the limitations of traditional carbon materials and support the growing demand for efficient energy storage solutions.
Applied Identity
Series C in 2008
Applied Identity, Inc. offers identity aware network security solutions. It offers ID-Audit, which displays real-time and historical user and resource activity; ID-Unify that enables the management of user identities between disparate identity stores; ID-Enforce, an identity aware network enforcement solution; and ID-Mark, which enables collection of audit data. The company also provides audit and compliance, asset protection, network level user and group separation, and identity virtualization solutions. Its clients include financial services, government department and agencies, technology innovators, and educational institutions.
Carbonflow
Series A in 2008
CarbonFlow is a developer of carbon trading software focused on addressing climate change by streamlining the creation and marketing of carbon offsets. Founded in 2006, the company aims to lower the costs and time associated with generating carbon credits. Its software suite enhances productivity while reducing administrative expenses and financial risks linked to managing greenhouse gas offset projects. Additionally, CarbonFlow facilitates the delivery of certified carbon credits to buyers and sellers globally, thereby supporting the acceleration of carbon reduction initiatives.
DepotPoint
Series C in 2008
DepotPoint specializes in software solutions for the distressed property market, emphasizing transparency, efficiency, and intelligence. Established in 2005 and headquartered in Bellevue, Washington, the company offers a web-based tracking platform tailored for the real estate foreclosure market. Its core products include the TrackPoint Platform, which enables users to manage property files throughout the default process, and ForeclosurePoint, a marketing platform that provides essential resources for real estate professionals and buyers. Through its innovative technology and user-friendly solutions, DepotPoint aims to streamline operations within the default real estate sector in the United States.
PrecisionDemand
Series A in 2008
PrecisionDemand is a television media agency located in Seattle and New York, focused on enhancing the effectiveness of advertising through advanced analytics. The company specializes in targeting TV audiences with high precision, utilizing a technology platform that incorporates extensive demographic and behavioral data. PrecisionDemand's Buyometric targeting system allows clients to significantly reduce their cost-per-sale while accurately predicting sales volumes across various channels. In addition to its targeting capabilities, the company provides a suite of direct marketing services that includes tracking and analyzing marketing campaigns, customer interactions, and operational metrics. Their offerings include detailed dashboards and reports that measure campaign performance, conversion rates, and revenue, enabling clients to make informed decisions to optimize their media purchases. With a team of experts in media, technology, and data mining, PrecisionDemand aims to deliver value and improve marketing outcomes for its clients.
Vantos
Series B in 2008
Vantos is a company specializing in enterprise investigation management, aiming to lead the global market in this sector. It provides comprehensive solutions for a range of investigative needs, from minor workplace misconduct to complex international financial crimes. Vantos offers V-Flex, a platform designed to automate and manage various investigative processes, along with analytics and visualization tools that help investigators identify trends and root causes in their data. The company also develops investigative playbooks, which facilitate the execution of common investigations efficiently and effectively. By addressing the evolving needs of organizations, Vantos seeks to streamline the investigation lifecycle and reduce associated costs.
Talyst
Series C in 2008
Talyst, founded in 2002, specializes in automated medication management systems aimed at enhancing patient safety across various care settings, including acute care hospitals, long-term care facilities, and correctional institutions. In 2003, the company introduced AutoPharm®, a comprehensive software platform that integrates medication storage, inventory management, ordering, barcoding, and clinical systems. This innovative approach not only streamlines pharmacy operations but also improves workflow efficiency and patient safety, addressing the critical needs of healthcare providers in managing medications effectively.
Tigo Energy
Series A in 2008
Tigo Energy, Inc. specializes in developing module-level power electronics and module optimizer technology for the solar industry. The company offers solar optimizers and comprehensive software solutions that include module-level monitoring for utility, commercial, and residential photovoltaic (PV) arrays, as well as a mobile application for solar management. Tigo Energy also provides communication solutions, such as gateways and a Maximizer Management Unit, which facilitate communication between optimizers and inverters. Its products cater to a diverse range of markets, including residential, commercial, utility, third-party finance, schools, and government sectors, and are distributed through various channels. Founded in 2007 and headquartered in Campbell, California, with an additional office in Tuscany, Italy, Tigo Energy operates globally across the United States, Europe, Japan, China, Australia, Brazil, and the Middle East. The company's focus is on enhancing safety, increasing energy yield, and reducing operating costs, ultimately improving the efficiency and reliability of solar installations.
Avenda Systems
Series B in 2008
Avenda Systems introduced the industry's first multi-function platform for network access control (NAC) and security that breaks through past deployment barriers found in early competitive solutions complexity, compatibility, compliance and cost. Avenda's flagship eTIPS solution is a scalable AAA platform that utilizes identity-based policies to manage access control, endpoint health and device authorization for wired, wireless and VPN networks. Users are granted differentiated privileges to control which network resources and applications they can access. Employee's roles, location, and the health of their computer can be used as determining factors. Visitors can be granted Internet only access if required. Partnerships with Cisco, Microsoft and top wireless vendors ensure that Avenda's solution fits into any network environment.
TZero Technologies
Series C in 2008
TZero Technologies designs and develops ultra wideband semiconductors for video distribution. The company offers wirelessly connects devices and ultra wideband chipsets, which connect audiovisual components, such as televisions, set-top boxes, and digital video recorders. It serves consumer electronics, service providers, and computer manufacturers. The company was founded in 2003 and is headquartered in Sunnyvale, California.
AdmitOne Security
Series C in 2008
AdmitOne Security is a software-as-a-service (SaaS) company located in Issaquah, Washington, that specializes in authentication and anti-fraud solutions. The company provides advanced user authentication software that leverages typing characteristics to verify and secure access to computer systems. By focusing on unique behavioral patterns, AdmitOne Security aims to enhance security measures, ensuring that only authorized users can access sensitive information and systems.
Max-Viz
Venture Round in 2008
Max-Viz is a specialized manufacturer of Enhanced Vision Systems for the aviation industry, focusing exclusively on the design, development, and production of infrared vision systems for aircraft. The company aims to enhance safety for both civilian and military aviation by providing technology that effectively penetrates fog, haze, smoke, and darkness. With a dedicated team of experienced scientists and engineers, Max-Viz is committed to advancing aviation safety through innovative visual solutions.
GainSpan
Series B in 2007
GainSpan specializes in ultra-low-power Wi-Fi technology aimed at enhancing sensors and embedded applications. Founded in 2006 by a team of engineers from Intel, the company focuses on creating semiconductor solutions that enable devices to operate for years on a single AA battery. This innovation addresses the challenges faced by wireless sensor networks, particularly issues related to power consumption and the need for standardized solutions. GainSpan's integrated system-on-chip combines a radio, media access controller, baseband processor, on-chip flash memory, and an applications processor, facilitating the development of connected products for smart homes and cities. The technology supports various applications, including temperature monitoring for energy management and condition monitoring of industrial equipment, allowing users to leverage existing Wi-Fi infrastructure and knowledge for new IoT opportunities.
Adapx
Series A in 2007
Adapx, Inc. is a software company based in Seattle, Washington, that specializes in user interface solutions designed to enhance data capture and integration for businesses and agencies. The company's primary offering, Capturx, enables users to convert natural speech, sketches, and handwriting into structured data for Microsoft Office and other backend systems. This solution helps streamline workflows by eliminating the need for data transcription and allows for efficient data collection through various mediums, including paper, touchscreens, and mobile devices. Adapx provides several tailored applications, such as Capturx for SharePoint, Capturx Forms for Excel, and Capturx for ArcGIS Desktop, among others. The company serves multiple industries, including manufacturing, defense, healthcare, and utilities. Additionally, Adapx has established strategic partnerships with major organizations like Microsoft and ESRI to enhance its product offerings. Founded in 1999, Adapx was previously known as Natural Interaction Systems.
Fate Therapeutics
Series A in 2007
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing programmed cellular immunotherapies for cancer and immune disorders. The company specializes in NK- and T-cell immuno-oncology programs, with a diverse pipeline that includes candidates such as FT516 and FT596 for treating various hematologic malignancies, FT538 for acute myeloid leukemia and multiple myeloma, and FT500 for advanced solid tumors. Fate Therapeutics employs advanced techniques involving induced pluripotent stem cells (iPSCs) to create engineered product candidates, which are designed to be off-the-shelf solutions. The company has established strategic collaborations with notable partners, including Ono Pharmaceutical Co. Ltd. and Janssen Biotech, to enhance its research and development capabilities. Founded in 2007, Fate Therapeutics aims to leverage cutting-edge science to create innovative therapies that restore health by modulating the properties of stem cells.
M2E Power
Series A in 2007
M2E Power specializes in developing energy generation technology solutions that provide clean power for mobile devices, including military applications. Founded in 2006 and based in Boise, Idaho, the company focuses on innovative battery technology that utilizes a micro generator to convert kinetic energy into electrical power. This technology is designed to generate and store energy for both military and consumer mobile devices. M2E Power was acquired by Motionetics in July 2009.
Ambric
Series B in 2007
Ambric specializes in the development and manufacturing of software-programmable interface circuits based on a massively parallel processor array architecture. The company has created a high-performance parallel processor solution that includes a structured object programming model, enabling developers to efficiently program a large number of cores. Ambric's inaugural chip architecture, the Am2045, features 336 processors on a single chip and is designed to compete with large FPGAs, DSPs, and Intel x86 processors in embedded markets. The company's products primarily target applications in video compression, medical imaging, wireless base stations, and military markets.
Allozyne
Series B in 2007
Allozyne, Inc. is a biopharmaceutical company based in Seattle, Washington, focused on developing innovative protein therapeutic candidates for autoimmune and inflammatory diseases, as well as cancer. Its lead product candidate, AZ01, is currently in a Phase 1b clinical trial aimed at treating relapsing-remitting multiple sclerosis. The company is also advancing AZ17, a bispecific antibody designed for various autoimmune and inflammatory conditions, including Crohn's disease and multiple sclerosis, and AZ05, an antibody-drug conjugate targeting solid tumors. Founded in 2004, Allozyne is dedicated to enhancing the efficacy, safety, and dosing of protein-based therapeutics, including peptides and antibodies. It operates as a subsidiary of Poniard Pharmaceuticals, Inc.
Accelerator Corp.
Series C in 2007
Accelerator Corporation, founded in 2003 and based in Seattle, Washington, is a venture capital firm that specializes in early-stage investments in biotechnology companies. The firm primarily invests up to $2 million in emerging growth and start-up ventures, focusing on identifying, evaluating, financing, and managing groundbreaking life sciences opportunities. Accelerator does not participate in subsequent financing rounds and typically maintains its investments for 12 to 24 months. The firm has developed a robust pipeline of deal flow through partnerships with top-tier investors and research institutions, providing access to state-of-the-art facilities and expertise in scientific and technical support. Over the past five years, Accelerator has invested in nine companies, three of which successfully raised follow-on financing exceeding $114 million. In total, Accelerator's portfolio companies have garnered over $143.5 million in initial and follow-on funding, supported by an additional commitment of $22.5 million from investors to further pursue innovative biotechnology opportunities. Through its unique resources and collaborations, Accelerator is positioned to streamline the development and commercialization of novel technologies in the biotechnology sector.
Verdezyne
Series C in 2007
Verdezyne is a private company focused on synthetic biology, utilizing its expertise and advanced computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. By optimizing commercial fermentation processes, Verdezyne produces renewable chemical alternatives to petrochemicals. The company’s innovative platform combines synthetic biology with established manufacturing technologies to create a wide range of building blocks, offering sustainable and cost-effective solutions for everyday chemicals and additives. This approach aims to reduce reliance on oil and transform traditional chemical production methods.
Serus
Series C in 2007
Serus Corporation specializes in intelligent operations management solutions for enterprises that outsource their manufacturing processes. The company provides a comprehensive suite of services aimed at enhancing business performance across various sectors, including semiconductor, consumer electronics, and original equipment manufacturing. Their offerings include transaction automation, operations planning, and WIP management solutions that improve network visibility and lot genealogy. Additionally, Serus delivers supply chain and demand planning tools, purchase order management, fulfillment solutions, and sales order management systems. The company also focuses on data aggregation and error resolution, offering managed services that encompass data modeling, process planning, and application management. Founded in 2000 and headquartered in Sunnyvale, California, Serus operates with a commitment to facilitating seamless integration of business processes among trading partners through its subscription and hosted service models.
Action Engine
Series E in 2007
Action Engine is a software development and data services agency that focuses on providing businesses with actionable intelligence to gain a competitive advantage. The company specializes in creating a browserless client/server platform that serves as a framework for developing and deploying application packs. These application packs offer intuitive and personalized methods for accessing and utilizing content. Action Engine's key solutions encompass mobile advertising, mobile search, social networking, and mobile entertainment, allowing clients to enhance their engagement and user experience across various digital platforms.
Virtugo Software
Venture Round in 2007
Virtugo Software provides software products that monitor, control, and optimize virtual and physical server environments. They deliver a workflow engine-based software platform that enables system integrators to automate system management processes for computing and communications environments. They provide the data necessary for performance monitoring, capacity management, resource optimization, and service metering.
NanoString Technologies
Series B in 2007
NanoString Technologies, Inc. is a provider of life science tools focused on translational research and molecular diagnostics, headquartered in Seattle, Washington. Established in 2003, the company utilizes a unique digital molecular barcoding technology to create a range of products that facilitate gene expression analysis, microRNA studies, and copy number variation detection. Key offerings include the nCounter Analysis System, which consists of the nCounter MAX and FLEX systems, and the nCounter SPRINT Profiler, all designed for automated sample processing and data collection. The nSolver Analysis Software aids researchers in data normalization and analysis. Additionally, NanoString provides various custom CodeSets and panels tailored for specific applications, including cancer profiling and autoimmune disease research. The company is advancing the field of spatial genomics with its GeoMx Digital Spatial Profiler system and is developing the Hyb & Seq molecular profiling system for gene sequence analysis. NanoString collaborates with several pharmaceutical companies and research institutions to enhance its product offerings and expand its impact in the scientific community.
Collaborative Software Initiative
Seed Round in 2007
Collaborative Software Initiative Inc., founded in 2007 and based in Portland, Oregon, develops and delivers enterprise software with a focus on innovative and cost-effective solutions. The company offers TriSano, a public health application designed for infectious disease surveillance, outbreak management, and bioterrorism response, catering to epidemiologists, health officials, and healthcare providers. By leveraging a collaborative approach, CSI engages community members, customers, and partners to create core teams that enhance the development process. This model allows for the creation of high-value software products under an open-source license or an annual subscription that includes commercial support. The company's emphasis on collaboration fosters innovation and results in sustainable software that adheres to open standards, ultimately providing greater business value to its diverse customer base.
AdmitOne Security
Series C in 2007
AdmitOne Security is a software-as-a-service (SaaS) company located in Issaquah, Washington, that specializes in authentication and anti-fraud solutions. The company provides advanced user authentication software that leverages typing characteristics to verify and secure access to computer systems. By focusing on unique behavioral patterns, AdmitOne Security aims to enhance security measures, ensuring that only authorized users can access sensitive information and systems.
Talyst
Series B in 2006
Talyst, founded in 2002, specializes in automated medication management systems aimed at enhancing patient safety across various care settings, including acute care hospitals, long-term care facilities, and correctional institutions. In 2003, the company introduced AutoPharm®, a comprehensive software platform that integrates medication storage, inventory management, ordering, barcoding, and clinical systems. This innovative approach not only streamlines pharmacy operations but also improves workflow efficiency and patient safety, addressing the critical needs of healthcare providers in managing medications effectively.
GenoLogics
Series B in 2006
GenoLogics, Inc. is a company that specializes in laboratory information management systems designed to enhance the diagnosis and treatment of diseases. Based in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers the BaseSpace Clarity LIMS, a solution utilized by research and clinical laboratories to efficiently track samples from receipt to result. This system aims to reduce costs, improve accuracy, and ensure rigorous quality control. The company focuses on translational medicine, genomics sequencing, systems biology research, and data management across multiple laboratories, facilitating collaborative initiatives in biomedical research. Founded in 2002, GenoLogics operates as a subsidiary of Illumina Inc., contributing to advancements in early disease detection, prevention, and treatment.
GainSpan
Series A in 2006
GainSpan specializes in ultra-low-power Wi-Fi technology aimed at enhancing sensors and embedded applications. Founded in 2006 by a team of engineers from Intel, the company focuses on creating semiconductor solutions that enable devices to operate for years on a single AA battery. This innovation addresses the challenges faced by wireless sensor networks, particularly issues related to power consumption and the need for standardized solutions. GainSpan's integrated system-on-chip combines a radio, media access controller, baseband processor, on-chip flash memory, and an applications processor, facilitating the development of connected products for smart homes and cities. The technology supports various applications, including temperature monitoring for energy management and condition monitoring of industrial equipment, allowing users to leverage existing Wi-Fi infrastructure and knowledge for new IoT opportunities.
Virtugo Software
Series B in 2006
Virtugo Software provides software products that monitor, control, and optimize virtual and physical server environments. They deliver a workflow engine-based software platform that enables system integrators to automate system management processes for computing and communications environments. They provide the data necessary for performance monitoring, capacity management, resource optimization, and service metering.
TZero Technologies
Series B in 2006
TZero Technologies designs and develops ultra wideband semiconductors for video distribution. The company offers wirelessly connects devices and ultra wideband chipsets, which connect audiovisual components, such as televisions, set-top boxes, and digital video recorders. It serves consumer electronics, service providers, and computer manufacturers. The company was founded in 2003 and is headquartered in Sunnyvale, California.
VLST Corporation
Series B in 2006
VLST Corporation is a privately held biotechnology company that has developed a novel and streamlined approach to speed the development of effective therapeutics for the treatment of inflammatory and autoimmune diseases. The VLST platform uses novel bioinformatics and state-of-the-art proteomics, to identify viral genes whose protein products function as immunomodulatory agents. The resulting product candidates will be either human homologues to these virulence factors or monoclonal antibodies that mimic the function of the virulence gene products. This approach allows for the efficient identification of high quality, pre-validated drug targets for the treatment of autoimmune and inflammatory disorders. The Company's technology has identified potential product candidates for the treatment of disorders such as multiple sclerosis, lupus, psoriasis, rheumatoid arthritis and diabetes.
Applied Identity
Series B in 2006
Applied Identity, Inc. offers identity aware network security solutions. It offers ID-Audit, which displays real-time and historical user and resource activity; ID-Unify that enables the management of user identities between disparate identity stores; ID-Enforce, an identity aware network enforcement solution; and ID-Mark, which enables collection of audit data. The company also provides audit and compliance, asset protection, network level user and group separation, and identity virtualization solutions. Its clients include financial services, government department and agencies, technology innovators, and educational institutions.
Complete Genomics
Series A in 2006
Complete Genomics specializes in high-quality, affordable DNA sequencing and analysis, facilitating large-scale research into the genetic mechanisms of drug responses and complex diseases. The company has developed a comprehensive genomics analysis platform that integrates proprietary human sequencing technology with advanced informatics and data management software. This approach ensures that customers receive ready-to-use data for genome-based research, supporting advancements in personalized medicine and broader genetic studies. By combining innovative technology with a unique market strategy, Complete Genomics aims to transform the landscape of DNA sequencing.
Allozyne
Series A in 2005
Allozyne, Inc. is a biopharmaceutical company based in Seattle, Washington, focused on developing innovative protein therapeutic candidates for autoimmune and inflammatory diseases, as well as cancer. Its lead product candidate, AZ01, is currently in a Phase 1b clinical trial aimed at treating relapsing-remitting multiple sclerosis. The company is also advancing AZ17, a bispecific antibody designed for various autoimmune and inflammatory conditions, including Crohn's disease and multiple sclerosis, and AZ05, an antibody-drug conjugate targeting solid tumors. Founded in 2004, Allozyne is dedicated to enhancing the efficacy, safety, and dosing of protein-based therapeutics, including peptides and antibodies. It operates as a subsidiary of Poniard Pharmaceuticals, Inc.
Scout Analytics
Series B in 2005
Scout Analytics is a leader in digital revenue optimization, specializing in enhancing the average revenue per user for publishers by 10-15 percent. The company offers a cloud-based recurring revenue management platform that transforms usage data into predictive analytics, allowing publishers to effectively analyze subscription usage, spending, and trial conversions. Their SaaS application utilizes patent-pending behavioral analytics technology to target and monetize user engagement, making it a valuable tool for both subscription and advertising revenue models. With a presence in over 70 publishing organizations, Scout Analytics provides solutions to reduce customer churn, increase renewal revenue, optimize rate plan performance, and maximize trial conversions. Headquartered in Issaquah, Washington, Scout Analytics is a venture-backed company committed to driving revenue growth for its clients.
Translarity
Series A in 2005
Translarity is a pioneering company in the semiconductor wafer test sector, specializing in advanced probe card solutions. Based in Silicon Valley, the company has introduced a disruptive full-wafer testing approach that emphasizes low cost, high performance, and reduced cycle times. In 2017, Translarity expanded its capabilities through the acquisition of BucklingBeam, enhancing its product offerings with a comprehensive range of probe card solutions, including full probe cards and vertical probe head technologies. The company's innovative Space Translator™ technology positions it well to meet the fast-evolving demands of probe technologies. With a strong management team and significant backing from financial investors, Translarity has built a robust innovation pipeline and intellectual property portfolio, boasting over 45 issued patents and more than 50 additional patents filed. The company aims to address critical challenges in semiconductor testing, facilitating efficient wafer-level and advanced package tests in the industry.
AdmitOne Security
Series B in 2005
AdmitOne Security is a software-as-a-service (SaaS) company located in Issaquah, Washington, that specializes in authentication and anti-fraud solutions. The company provides advanced user authentication software that leverages typing characteristics to verify and secure access to computer systems. By focusing on unique behavioral patterns, AdmitOne Security aims to enhance security measures, ensuring that only authorized users can access sensitive information and systems.
Vantos
Series A in 2005
Vantos is a company specializing in enterprise investigation management, aiming to lead the global market in this sector. It provides comprehensive solutions for a range of investigative needs, from minor workplace misconduct to complex international financial crimes. Vantos offers V-Flex, a platform designed to automate and manage various investigative processes, along with analytics and visualization tools that help investigators identify trends and root causes in their data. The company also develops investigative playbooks, which facilitate the execution of common investigations efficiently and effectively. By addressing the evolving needs of organizations, Vantos seeks to streamline the investigation lifecycle and reduce associated costs.
Integrated Diagnostics
Series A in 2005
Integrated Diagnostics Inc. specializes in the development of laboratory-based blood molecular diagnostic tools designed to assist physicians in the early detection of complex diseases through non-invasive blood tests. The company's flagship product, Xpresys Lung, provides objective information for assessing pulmonary nodules by monitoring multiple disease molecular markers simultaneously. Founded in 2005 and based in Seattle, Washington, Integrated Diagnostics aims to leverage emerging technologies to create a pipeline of innovative diagnostic products that facilitate the management of serious conditions such as cancer, diabetes, and Alzheimer's. The company operates under the principle that a systems view of disease, involving networks of proteins, genes, and other molecules, is essential for effective diagnosis and prognosis. Integrated Diagnostics is a subsidiary of Biodesix, Inc. and has established a strategic partnership with Agilent Technologies.
NanoString Technologies
Series A in 2005
NanoString Technologies, Inc. is a provider of life science tools focused on translational research and molecular diagnostics, headquartered in Seattle, Washington. Established in 2003, the company utilizes a unique digital molecular barcoding technology to create a range of products that facilitate gene expression analysis, microRNA studies, and copy number variation detection. Key offerings include the nCounter Analysis System, which consists of the nCounter MAX and FLEX systems, and the nCounter SPRINT Profiler, all designed for automated sample processing and data collection. The nSolver Analysis Software aids researchers in data normalization and analysis. Additionally, NanoString provides various custom CodeSets and panels tailored for specific applications, including cancer profiling and autoimmune disease research. The company is advancing the field of spatial genomics with its GeoMx Digital Spatial Profiler system and is developing the Hyb & Seq molecular profiling system for gene sequence analysis. NanoString collaborates with several pharmaceutical companies and research institutions to enhance its product offerings and expand its impact in the scientific community.
Airgo Networks
Series E in 2005
Airgo Networks is a California-based company specializing in the development of multiple-input multiple-output wireless technology.
GenoLogics
Series A in 2005
GenoLogics, Inc. is a company that specializes in laboratory information management systems designed to enhance the diagnosis and treatment of diseases. Based in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers the BaseSpace Clarity LIMS, a solution utilized by research and clinical laboratories to efficiently track samples from receipt to result. This system aims to reduce costs, improve accuracy, and ensure rigorous quality control. The company focuses on translational medicine, genomics sequencing, systems biology research, and data management across multiple laboratories, facilitating collaborative initiatives in biomedical research. Founded in 2002, GenoLogics operates as a subsidiary of Illumina Inc., contributing to advancements in early disease detection, prevention, and treatment.
Safeharbor Knowledge Solutions
Venture Round in 2005
Safeharbor Knowledge Solutions specializes in providing knowledge management solutions and software tools for forums and knowledge bases, particularly aimed at small and medium-sized businesses. Their flagship product, SmartSupport, offers a comprehensive platform that allows organizations to efficiently manage both internal and external knowledge. It enables administrators to optimize content, streamline management processes, and enhance the return on investment for support channels. With SmartSupport, users can quickly set up a knowledge base on their website, which helps in deflecting customer inquiries while improving overall customer service. Additionally, Safeharbor provides expertise in developing rich content and offers a suite of contact center and help desk services to ensure thorough customer support. The company's solutions also include tools for the optimization and consolidation of existing support articles, facilitating better management and collaboration among agents.
Accelerator Corp.
Venture Round in 2004
Accelerator Corporation, founded in 2003 and based in Seattle, Washington, is a venture capital firm that specializes in early-stage investments in biotechnology companies. The firm primarily invests up to $2 million in emerging growth and start-up ventures, focusing on identifying, evaluating, financing, and managing groundbreaking life sciences opportunities. Accelerator does not participate in subsequent financing rounds and typically maintains its investments for 12 to 24 months. The firm has developed a robust pipeline of deal flow through partnerships with top-tier investors and research institutions, providing access to state-of-the-art facilities and expertise in scientific and technical support. Over the past five years, Accelerator has invested in nine companies, three of which successfully raised follow-on financing exceeding $114 million. In total, Accelerator's portfolio companies have garnered over $143.5 million in initial and follow-on funding, supported by an additional commitment of $22.5 million from investors to further pursue innovative biotechnology opportunities. Through its unique resources and collaborations, Accelerator is positioned to streamline the development and commercialization of novel technologies in the biotechnology sector.
Ambric
Series A in 2004
Ambric specializes in the development and manufacturing of software-programmable interface circuits based on a massively parallel processor array architecture. The company has created a high-performance parallel processor solution that includes a structured object programming model, enabling developers to efficiently program a large number of cores. Ambric's inaugural chip architecture, the Am2045, features 336 processors on a single chip and is designed to compete with large FPGAs, DSPs, and Intel x86 processors in embedded markets. The company's products primarily target applications in video compression, medical imaging, wireless base stations, and military markets.
Intelligent Results
Series B in 2004
Intelligent Results enables companies in financial services, utilities, telecom, government, and retail to manage their business more dynamically with a new standard in customer analytics and decision management. The Intelligent Results PREDIGYTM software platform allows companies to better understand and predict customer behavior and then quickly plan and operationalize targeted strategies. This empowers companies to improve the customer experience, allocate resources more effectively, and increase profitability. Intelligent Results’ approach, platform and applications result from 20 years experience that began in the national labs
Airgo Networks
Series D in 2004
Airgo Networks is a California-based company specializing in the development of multiple-input multiple-output wireless technology.
Intelligent Results
Series B in 2003
Intelligent Results enables companies in financial services, utilities, telecom, government, and retail to manage their business more dynamically with a new standard in customer analytics and decision management. The Intelligent Results PREDIGYTM software platform allows companies to better understand and predict customer behavior and then quickly plan and operationalize targeted strategies. This empowers companies to improve the customer experience, allocate resources more effectively, and increase profitability. Intelligent Results’ approach, platform and applications result from 20 years experience that began in the national labs
Airgo Networks
Series C in 2003
Airgo Networks is a California-based company specializing in the development of multiple-input multiple-output wireless technology.
Entomo
Series C in 2003
Entomo, Inc. specializes in providing cloud-based Channel Control and Revenue Management solutions aimed at helping businesses navigate the complexities of distribution channels. Their integrated software platform includes applications for data aggregation, channel incentive management, commission splits, and inventory price protection. By offering enhanced visibility and control over channel operations, Entomo enables organizations to automate workflows, simplify processes, and foster better collaboration with partners. This ultimately supports revenue growth while reducing costs and ensuring compliance across the channel ecosystem.
Max-Viz
Venture Round in 2002
Max-Viz is a specialized manufacturer of Enhanced Vision Systems for the aviation industry, focusing exclusively on the design, development, and production of infrared vision systems for aircraft. The company aims to enhance safety for both civilian and military aviation by providing technology that effectively penetrates fog, haze, smoke, and darkness. With a dedicated team of experienced scientists and engineers, Max-Viz is committed to advancing aviation safety through innovative visual solutions.
Safeharbor Knowledge Solutions
Venture Round in 2002
Safeharbor Knowledge Solutions specializes in providing knowledge management solutions and software tools for forums and knowledge bases, particularly aimed at small and medium-sized businesses. Their flagship product, SmartSupport, offers a comprehensive platform that allows organizations to efficiently manage both internal and external knowledge. It enables administrators to optimize content, streamline management processes, and enhance the return on investment for support channels. With SmartSupport, users can quickly set up a knowledge base on their website, which helps in deflecting customer inquiries while improving overall customer service. Additionally, Safeharbor provides expertise in developing rich content and offers a suite of contact center and help desk services to ensure thorough customer support. The company's solutions also include tools for the optimization and consolidation of existing support articles, facilitating better management and collaboration among agents.
Action Engine
Series B in 2002
Action Engine is a software development and data services agency that focuses on providing businesses with actionable intelligence to gain a competitive advantage. The company specializes in creating a browserless client/server platform that serves as a framework for developing and deploying application packs. These application packs offer intuitive and personalized methods for accessing and utilizing content. Action Engine's key solutions encompass mobile advertising, mobile search, social networking, and mobile entertainment, allowing clients to enhance their engagement and user experience across various digital platforms.
Intelligent Results
Series A in 2002
Intelligent Results enables companies in financial services, utilities, telecom, government, and retail to manage their business more dynamically with a new standard in customer analytics and decision management. The Intelligent Results PREDIGYTM software platform allows companies to better understand and predict customer behavior and then quickly plan and operationalize targeted strategies. This empowers companies to improve the customer experience, allocate resources more effectively, and increase profitability. Intelligent Results’ approach, platform and applications result from 20 years experience that began in the national labs
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.